NewBiotics Report issue

For profit Phase 2
Founded: San Diego CA United States (1997)
Status: Acquired by CellMed AG (2004) → now Boston Scientific Corporation (2018)

Organization Overview

First Clinical Trial
2001
NCT00031616
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

brivudine phosphoramidate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1